Lrig1 Is a Positive Prognostic Marker in Hepatocellular Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s112534
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

Senescence Marker Protein 30 (SMP30) Serves as a Potential Prognostic Indicator in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

Senescence-Associated Protein P400 Is a Prognostic Marker in Renal Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2013English

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker After Curative Resection of HBV-Related Hepatocellular Carcinoma”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2017English

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

Prognostic Role of HepPar1 Positive Circulating Microparticles After Hepatectomy for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2018English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

miR‑939‑3p Promotes Epithelial‑mesenchymal Transition and May Be Used as a Prognostic Marker in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy